Farmington, Conn.-based UConn Health has expanded its cancer care services with the addition of CAR-T cell therapy.
UConn Health’s Carole and Ray Neag Comprehensive Cancer Center is the second to offer CAR-T cell therapy in Connecticut, according to a Sept. 29 news release from the health system.
“So many people across UConn Health recognized the value of bringing this treatment here and worked together to make it possible,” Kapil Meleveedu, MD, director of UConn Health’s Blood and Marrow Transplant and Cellular Therapy Program, said in the release. “After nearly two years of preparation, we are ready to provide this therapy safely and effectively.”
UConn Health care teams have begun the cell collection process for the program’s first patient undergoing CAR-T cell therapy, the release said.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
